US Stock MarketDetailed Quotes

AEON Biopharma (AEON)

Watchlist
  • 1.0200
  • +0.0320+3.24%
Close Apr 17 15:58 ET
  • 1.0499
  • +0.0299+2.93%
Post 20:01 ET
25.81MMarket Cap-0.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AEON Biopharma (AEON) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.71%-17.31M
-658.78%-4.71M
12.15%-2.6M
74.24%-2.09M
8.03%-7.91M
-20.29M
-621K
-2.96M
19.52%-8.12M
22.23%-8.6M
Net income from continuing operations
-193.37%-39.22M
-1,883.72%-37.14M
26.46%-4.54M
-104.05%-6.64M
107.71%9.1M
--42.01M
--2.08M
---6.17M
1,167.12%164.11M
-569.07%-118.02M
Operating gains losses
-88.95%3.8M
1,631.38%14.1M
-19.93%237K
106.15%542K
-125.30%-11.09M
--34.39M
---921K
--296K
---8.81M
--43.82M
Depreciation and amortization
-19.59%78K
-13.04%20K
-24.00%19K
-16.67%20K
-24.00%19K
--97K
--23K
--25K
4.35%24K
0.00%25K
Other non cash items
118.95%19.66M
376.45%17.81M
-2.02%1.84M
101.15%1.87M
-102.91%-1.86M
---103.74M
---6.44M
--1.88M
-11,320.10%-163.03M
1,271.18%63.86M
Change In working capital
-1,083.14%-6.94M
-133.38%-1.1M
1.56%-568K
125.47%537K
-6,152.08%-5.81M
--706K
--3.3M
---577K
-178.86%-2.11M
-82.19%96K
-Change in prepaid assets
330.99%1.19M
324.90%1.09M
126.89%338K
-85.40%53K
-340.32%-298K
---513K
--257K
---1.26M
6,150.00%363K
217.95%124K
-Change in payables and accrued expense
-752.78%-7.17M
-141.21%-1.25M
-232.11%-901K
119.30%488K
-5,888.04%-5.51M
--1.1M
--3.04M
--682K
-192.43%-2.53M
-120.00%-92K
-Change in other working capital
-893.33%-952K
---940K
-150.00%-5K
-106.90%-4K
-104.69%-3K
--120K
--0
---2K
201.75%58K
60.00%64K
Cash from discontinued investing activities
Operating cash flow
14.71%-17.31M
-658.78%-4.71M
12.15%-2.6M
74.24%-2.09M
8.03%-7.91M
---20.29M
---621K
---2.96M
19.52%-8.12M
22.23%-8.6M
Investing cash flow
Cash flow from continuing investing activities
-4K
0
0
0
-4K
0
0
0
0
0
Net PPE purchase and sale
---4K
--0
--0
--0
---4K
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
---4K
--0
--0
--0
---4K
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
34.05%20.31M
1,746.39%1.79M
68.00%84K
-99.16%84K
266.92%18.35M
15.15M
97K
50K
25.00%10M
-16.67%5M
Net issuance payments of debt
--0
--0
--0
--0
--0
--15M
--0
--0
25.00%10M
-16.67%5M
Net common stock issuance
12,494.56%18.51M
--0
68.00%84K
--84K
--18.35M
--147K
--97K
--50K
--0
--0
Net other financing activities
--1.79M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
34.05%20.31M
1,746.39%1.79M
68.00%84K
-99.16%84K
266.92%18.35M
--15.15M
--97K
--50K
25.00%10M
-16.67%5M
Net cash flow
Beginning cash position
-99.75%13K
1,003.72%5.93M
145.18%8.44M
570.47%10.45M
-99.75%13K
--5.16M
--537K
--3.44M
-66.77%1.56M
-47.08%5.16M
Current changes in cash
158.17%2.99M
-457.44%-2.92M
13.53%-2.51M
-206.53%-2.01M
389.81%10.43M
---5.15M
---524K
---2.91M
190.36%1.88M
28.83%-3.6M
End cash Position
23,023.08%3.01M
23,023.08%3.01M
1,003.72%5.93M
145.18%8.44M
570.47%10.45M
--13K
--13K
--537K
32.23%3.44M
-66.77%1.56M
Free cash flow
14.69%-17.31M
-658.78%-4.71M
12.15%-2.6M
74.24%-2.09M
7.99%-7.91M
---20.29M
---621K
---2.96M
19.52%-8.12M
22.23%-8.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.71%-17.31M-658.78%-4.71M12.15%-2.6M74.24%-2.09M8.03%-7.91M-20.29M-621K-2.96M19.52%-8.12M22.23%-8.6M
Net income from continuing operations -193.37%-39.22M-1,883.72%-37.14M26.46%-4.54M-104.05%-6.64M107.71%9.1M--42.01M--2.08M---6.17M1,167.12%164.11M-569.07%-118.02M
Operating gains losses -88.95%3.8M1,631.38%14.1M-19.93%237K106.15%542K-125.30%-11.09M--34.39M---921K--296K---8.81M--43.82M
Depreciation and amortization -19.59%78K-13.04%20K-24.00%19K-16.67%20K-24.00%19K--97K--23K--25K4.35%24K0.00%25K
Other non cash items 118.95%19.66M376.45%17.81M-2.02%1.84M101.15%1.87M-102.91%-1.86M---103.74M---6.44M--1.88M-11,320.10%-163.03M1,271.18%63.86M
Change In working capital -1,083.14%-6.94M-133.38%-1.1M1.56%-568K125.47%537K-6,152.08%-5.81M--706K--3.3M---577K-178.86%-2.11M-82.19%96K
-Change in prepaid assets 330.99%1.19M324.90%1.09M126.89%338K-85.40%53K-340.32%-298K---513K--257K---1.26M6,150.00%363K217.95%124K
-Change in payables and accrued expense -752.78%-7.17M-141.21%-1.25M-232.11%-901K119.30%488K-5,888.04%-5.51M--1.1M--3.04M--682K-192.43%-2.53M-120.00%-92K
-Change in other working capital -893.33%-952K---940K-150.00%-5K-106.90%-4K-104.69%-3K--120K--0---2K201.75%58K60.00%64K
Cash from discontinued investing activities
Operating cash flow 14.71%-17.31M-658.78%-4.71M12.15%-2.6M74.24%-2.09M8.03%-7.91M---20.29M---621K---2.96M19.52%-8.12M22.23%-8.6M
Investing cash flow
Cash flow from continuing investing activities -4K000-4K00000
Net PPE purchase and sale ---4K--0--0--0---4K--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ---4K--0--0--0---4K--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 34.05%20.31M1,746.39%1.79M68.00%84K-99.16%84K266.92%18.35M15.15M97K50K25.00%10M-16.67%5M
Net issuance payments of debt --0--0--0--0--0--15M--0--025.00%10M-16.67%5M
Net common stock issuance 12,494.56%18.51M--068.00%84K--84K--18.35M--147K--97K--50K--0--0
Net other financing activities --1.79M------------------------------------
Cash from discontinued financing activities
Financing cash flow 34.05%20.31M1,746.39%1.79M68.00%84K-99.16%84K266.92%18.35M--15.15M--97K--50K25.00%10M-16.67%5M
Net cash flow
Beginning cash position -99.75%13K1,003.72%5.93M145.18%8.44M570.47%10.45M-99.75%13K--5.16M--537K--3.44M-66.77%1.56M-47.08%5.16M
Current changes in cash 158.17%2.99M-457.44%-2.92M13.53%-2.51M-206.53%-2.01M389.81%10.43M---5.15M---524K---2.91M190.36%1.88M28.83%-3.6M
End cash Position 23,023.08%3.01M23,023.08%3.01M1,003.72%5.93M145.18%8.44M570.47%10.45M--13K--13K--537K32.23%3.44M-66.77%1.56M
Free cash flow 14.69%-17.31M-658.78%-4.71M12.15%-2.6M74.24%-2.09M7.99%-7.91M---20.29M---621K---2.96M19.52%-8.12M22.23%-8.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -